| 000 | 01653 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513131358.0 | ||
| 264 | 0 | _c19971210 | |
| 008 | 199712s 0 0 eng d | ||
| 022 | _a1380-2933 | ||
| 024 | 7 |
_a10.1016/1380-2933(96)00425-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKola, A | |
| 245 | 0 | 0 |
_aEpitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis. _h[electronic resource] |
| 260 |
_bImmunotechnology : an international journal of immunological engineering _cJun 1996 |
||
| 300 |
_a115-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aAntibody Specificity |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aComplement C5a _xchemistry |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aEpitope Mapping |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aPeptide Library |
| 650 | 0 | 4 | _aReceptor, Anaphylatoxin C5a |
| 650 | 0 | 4 |
_aReceptors, Complement _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aBaensch, M | |
| 700 | 1 | _aBautsch, W | |
| 700 | 1 | _aHennecke, M | |
| 700 | 1 | _aKlos, A | |
| 700 | 1 | _aCasaretto, M | |
| 700 | 1 | _aKöhl, J | |
| 773 | 0 |
_tImmunotechnology : an international journal of immunological engineering _gvol. 2 _gno. 2 _gp. 115-26 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/1380-2933(96)00425-3 _zAvailable from publisher's website |
| 999 |
_c9343206 _d9343206 |
||